The influence of NMDA and GABAA receptors and glutamic acid decarboxylase (GAD) activity on attention

Psychopharmacology

Volumn 225, Issue 1, 2013, Pages 31-39

  Pehrson, Alan L ^a,b   Bondi, Corina O ^a   Totah, Nelson K B ^a,c   Moghaddam, Bita ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LUNDBECK RESEARCH USA   (United States)

^c MAX PLANCK INSTITUTE FOR BIOLOGICAL CYBERNETICS   (Germany)

Author keywords

Attention; GABA; Glutamate; Glutamic acid decarboxylase; Schizophrenia

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3 MERCAPTOPROPIONIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; DIZOCILPINE; GLUTAMATE DECARBOXYLASE; N METHYL BETA CARBOLINE 3 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

4 AMINOBUTYRIC ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; ATTENTION; CONTROLLED STUDY; GABAERGIC TRANSMISSION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TASK PERFORMANCE;

3-MERCAPTOPROPIONIC ACID; ANIMALS; ATTENTION; CARBOLINES; COGNITION DISORDERS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; GLUTAMATE DECARBOXYLASE; GYRUS CINGULI; MALE; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84872319087     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2792-z     Document Type: Article

References (58)

1. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry 156:1646-1649
2. Ahn K, Gil R, Seibyl J, Sewell RA, D'Souza DC (2011) Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology 36:677-683
3. Akbarian Rt (1995) Reduced inhibitory capacity in prefrontal cortex of schizophrenics. Archives of General Psychiatry 52:267-278
4. Andreasen NC (1999) A unitary model of schizophrenia - Bleuler's "fragmented phrene" as schizencephaly. Archives of General Psychiatry 56:781-787
5. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K (2010) Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nature neuroscience 13:76-83
6. Brier A, Davis O, Buchanan R, Listwak SJ, Holmes C, Pickar D, Goldstein DS (1992) Effects of alprazolam on pituitary-adrenal and catecholaminergic response to metabolic stress in humans. Biological Psychiatry 32:880-890
7. Bussey T, Muir J, Everitt B, Robbins T (1997) Triple dissociation of anterior cingulate, posterior cingulate, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behavioral Neuroscience 11:920-936
8. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380
9. Carli M, Baviera M, Invernizzi RW, Balducci C (2006) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 31:757-767
10. Chudasama Y, Passetti F, Rhodes SE, Lopian D, Desai A, Robbins TW (2003) Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146:105-119
11. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE (1991) Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci 11:2383-2402
12. Curley AA, Lewis DA (2012) Cortical basket cell dysfunction in schizophrenia. J Physiol 590:715-724
13. Francois J, Ferrandon A, Koning E, Angst MJ, Sandner G, Nehlig A (2009) Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats. Int J Neuropsychopharmacol 12:1097-1110
14. Gold JM (2004) Cognitive deficits as treatment targets in schizophrenia. Schizophr Res 72:21-28
15. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC (1999) Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. American Journal of Psychiatry 156:1342-1348
16. Goldberg TE, Weinberger DR (1987) Methodological issues in the neuropsychological approach to schizophrenia. Elsevier Science, New York
17. Gonzalez-Burgos G, Hashimoto T, Lewis DA (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 12:335-344
18. Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Hayashi K, Oonari N, Korogi Y, Nakamura J (2009) Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3 T Proton MRS study. Schizophr Res 112:192-193
19. Green M (1996) What are the functional consequences of neurocognitive deficits in schizophrenia. American Journal of Psychiatry 153:321-330
20. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the «right stuff»? Schizophr Bull 26:119-136
21. Grottick AJ, Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117:197-208
22. Herbison AE, Heavens RP, Dyer RG (1990) Endogenous release of gamma-aminobutyric acid from the medial preoptic area measured by microdialysis in the anaesthetised rat. J. Neurochem 55(5):1617-1623
23. Huang-Pollock CL, Karalunas SL, Tam H, Moore AN (2012) Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnormal Psychol 121:360-371
24. Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC (2012) Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry 69:449-459
25. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
26. Lamar C Jr (1970) Mercaptopropionic acid: a convulsant that inhibits glutamate decarboxylase. J Neurochem 17:165-170
27. Laurent A, Saoud M, Bougerol T, d'Amato T, Anchisi AM, Biloa-Tang M, Dalery J, Rochet T (1999) Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Psychiatry Res 89:147-159
28. Lewis DA, Moghaddam B (2006) Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63:1372-1376
29. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312-324
30. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR (2003) Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci 18:391-402
31. Luck SJ, Ford JM, Sarter M, Lustig C (2012) CNTRICS final biomarker selection: control of attention. Schizophrenia bulletin 38:53-61
32. Martin DL, Rimvall K (1993) Regulation of gamma-aminobutyric acid synthesis in the brain. Journal of Neurochemistry 60:395-407
33. Marvel CL, Paradiso S (2004) Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 27:19-36, vii-viii
34. Mazurkiewicz M, Sirvio J, Riekkinen P Sr (1992) Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task. Epilepsy Res 13:231-237
35. Miner LA, Sarter M (1999) Intra-accumbens infusions of antisense oligodeoxynucleotides to one isoform of glutamic acid decarboxylase mRNA, GAD65, but not to GAD67 mRNA, impairs sustained attention performance in the rat. Brain Res Cogn Brain Res 7:269-283
36. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cerebral Cortex 6:470-481
37. Murphy ER, Fernando AB, Urcelay GP, Robinson ES, Mar AC, Theobald DE, Dalley JW, Robbins TW (2012) Impulsive behaviour induced by both NMDA receptor antagonism and GABA(A) receptor activation in rat ventromedial prefrontal cortex. Psychopharmacology 219:401-410
38. Ongur D, Prescot AP, McCarthy J, Cohen BM, Renshaw PF (2010) Elevated gamma-aminobutyric acid levels in chronic schizophrenia. Biological psychiatry 68:667-670
39. Paine TA, Carlezon WA Jr (2009) Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats. Neuropharmacology 56:788-797
40. Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA Jr (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62:687-693
41. Paine TA, Slipp LE, Carlezon WA Jr (2011) Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors. Neuropsychopharmacology 36:1703-1713
42. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, San Diego
43. Payne R (1961) Cognitive abnormalities. Basic Books, New York
44. Porter RJ, Bourke C, Gallagher P (2007) Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry 41:115-128
45. Ragozzino ME, Rozman S (2007) The effect of rat anterior cingulate inactivation on cognitive flexibility. Behav Neurosci 121:698-706
46. Ross SM (2003) Peirce's criterion for the elimination of suspect experimental data. J Eng Technol 20:38-41
47. Rudolph U, Knoflach F (2011) Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 10:685-697
48. Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Ueno S, Harada M, Ohmori T (2010) GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schiz research 117:83-91
49. Thompson M, Weickert CS, Wyatt E, Webster MJ (2009) Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res 43:970-977
50. Totah NK, Kim YB, Homayoun H, Moghaddam B (2009) Anterior cingulate neurons represent errors and preparatory attention within the same behavioral sequence. The Journal of neuroscience: the official journal of the Society for Neuroscience 29:6418-6426
51. Totah NK, Jackson ME, Moghaddam B (2012) Preparatory attention relies on dynamic interactions between prelimbic cortex and anterior cingulate cortex. Cerebral Cortex doi: 10.1093/cercor/bhs057
52. Turner CP, DeBenedetto D, Ware E, Stowe R, Lee A, Swanson J, Walburg C, Lambert A, Lyle M, Desai P, Liu C (2010) Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin. Exp Brain Res 201:479-488
53. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100-113
54. Vanini G, Watson CJ, Lydic R, Baghdoyan HA (2008) Gamma-aminobutyric acid-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 109(6):978-988.
55. Volk DW, Lewis DA (2002) Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77:501-505
56. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245
57. Volk D, Austin M, Pierri J, Sampson A, Lewis D (2001) GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158:256-265
58. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter CS (2010) GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 30:3777-3781